Novartis Ag (NVS) Return on Invested Capital (2009 - 2024)

Novartis Ag (NVS) has 7 years of Return on Invested Capital data on file, last reported at 0.05% in Q2 2025.

• Quarterly Return on Invested Capital fell 411.0% year-over-year to 0.05% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 0.05% (down 411.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.05% in Q2 2025 per NVS's latest filing, from 0.02% in the prior quarter.
• The five-year high for Return on Invested Capital was 101.14% in Q3 2022, with the low at 0.01% in Q4 2021.
• Average Return on Invested Capital over 5 years is 12.89%, with a median of 1.28% recorded in 2023.
• Year-over-year, Return on Invested Capital surged 10111 bps in 2022 and plunged 2354 bps in 2023.
• Novartis Ag's Return on Invested Capital stood at 0.01% in 2021, then jumped by 141211 bps to 7.59% in 2022, then sank by 81 bps to 1.44% in 2023, then slumped by 99 bps to 0.02% in 2024, then surged by 204 bps to 0.05% in 2025.
• Business Quant data shows NVS's Return on Invested Capital at 0.05% in Q2 2025, 0.02% in Q4 2024, and 4.16% in Q2 2024.